InvestorsHub Logo
Followers 15
Posts 1189
Boards Moderated 1
Alias Born 12/31/2008

Re: jay one post# 686

Thursday, 01/09/2014 5:12:49 PM

Thursday, January 09, 2014 5:12:49 PM

Post# of 4523
Yeah, it seems to be respecting this area for the moment. Be interesting to see if it keeps up this way without news. It sure made a quick move from 2.53ish to 2.60 EOD.

I thought there was going to be a date announced a week or so ago for an ADCOM date if I remember correctly. That might push it up to 3? Or, at least 2.8ish? Or is that news already baked in to the price? Not sure, I have to review again.

From what I've found, there was a PR on their web site from Sep of last year(link: http://ir.enteromedics.com/releasedetail.cfm?ReleaseID=792796) stating, "We are very encouraged by the responsiveness of the FDA and are confident in our ability to address their questions in a timely manner," said Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer.

"We will continue to work closely with the FDA throughout this process. We believe that the Company continues on track for a panel in late Q4 2013/Q1 2014 with approval decision in the first half of 2014."

BiopharmCatalyst web site shows a date of: 3/31/14 - but I think that's a temp date. Anyone know?

link: http://www.biopharmcatalyst.com/fda-calendar/

Thanks


These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.